Supply of Nonchemotherapy Compounded Monoclonal Antibodies
Estimated value
—
Awarded value
—
Suppliers
4
Lots
1
Published
06 Oct 2025
Description
Pharmacy Procurement Contract - Supply of Nonchemotherapy Compounded Monoclonal Antibodies. A Ranked Framework split into three LOTS<br/>LOT 1 - Infliximab Compounded Dose Banded Bags<br/>LOT 2 - Vedolizumab Compounded Bags<br/>LOT 3 - Natalizumab Compounded Bags<br/>The ranked framework will be open to participating Trusts of the South East Pharmacy Procurement Service.
Scope
- Reference
- PR BHFT 0535
- Commercial tool
- Standalone contract
- Main category
- goods
- Contract locations
- South East England
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Organisational Selection | 0 | quality | — |
| Technical Compliance | 40 | quality | — |
| Shelf Life | 15 | quality | — |
| Social Value | 10 | quality | — |
| Price | 35 | cost | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 4 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Award 1· 1 supplier
Awarded —
Award 2· 1 supplier
Awarded —
Award 3· 1 supplier
Awarded —
Award 4· 1 supplier
Awarded —
Other contracts from Berkshire Healthcare NHS Foundation Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Qualasept Ltd t/a Bath ASU· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Framework Agreement for the Provision of Dose Banded Chemotherapy Services | contract | £3.0m | 22 Jun 2026 |
| Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services | contract | — | 07 Apr 2026 |
| Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services | contract | — | 26 Jan 2026 |
| Framework for the supply of Ready to Administer Products | contract | — | 23 Oct 2025 |
| Framework for the supply of Ready to Administer Products | contract | — | 22 Sept 2025 |
| D105 - Ready to Administer Products | contract | — | 20 Aug 2025 |
| Aseptically Manipulated or Terminally Sterile Medicinal Products | contract | — | 20 Aug 2024 |
| Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5) | contract | — | 20 Aug 2024 |
| Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) | contract | — | 09 Aug 2024 |
| CM/PHR/22/5686- NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer | contract | — | 03 Apr 2024 |